Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Randomized phase II study of lapatinib plus vinorelbine versus vinorelbine in patients with HER2 positive metastatic breast cancer progressed after lapatinib and trastuzumab treatment
- Authors
- Sim, SH[Sim, S. H.]; Park, IH[Park, I. H.]; Jung, KH[Jung, K. H.]; Kim, SB[Kim, S-B]; Ahn, JH[Ahn, J-H]; Lee, KH[Lee, K-H]; Im, SA[Im, S-A]; Im, YH[Im, Y-H]; Park, YH[Park, Y. H.]; Sohn, JH[Sohn, J. H.]; Kim, YJ[Kim, Y. J.]; Lee, S[Lee, S.]; Kim, HJ[Kim, H-J]; Chae, YS[Chae, Y. S.]; Park, KH[Park, K-H]; Nam, BH[Nam, B-H]; Lee, KS[Lee, K. S.]; Ro, J[Ro, J.]
- Issue Date
- Feb-2019
- Publisher
- AMER ASSOC CANCER RESEARCH
- Citation
- CANCER RESEARCH, v.79, no.4
- Indexed
- SCIE
SCOPUS
- Journal Title
- CANCER RESEARCH
- Volume
- 79
- Number
- 4
- ISSN
- 0008-5472
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.